mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-12 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
8e-09 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-08 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-08 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-07 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-07 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-06 |